-
June 18, 2013
As per Reuters, several pharmaceutical companies have shown an interest in acquiring ViroPharma given the company's ...
-
June 18, 2013
Benchmarks chalked up gains on speculation that the Federal Reserve will implement policies in favor of ...
-
June 18, 2013
Shares of some top homebuilding companies traded higher at the close of trading on Monday, Jun 17, buoyed by ...
-
June 17, 2013
Weyerhaeuser makes a serious of moves that should build long-term value
-
June 14, 2013
Shares of some top homebuilding companies jumped during trading session on Thursday as the U.S. new home sales ...
-
June 12, 2013
ViroPharma recently received "orphan drug designation" in the EU for its pipeline candidate, maribavir, ...
-
June 11, 2013
Benchmarks ended flat on Monday despite Standard & Poor revising United States’ outlook to stable from ...
-
February 14, 2013
Peregrine Pharmaceuticals (PPHM) recently announced phase II data on its oncology candidate, bavituximab. The ...
-
February 12, 2013
Recently, Celgene Corporation (CELG) announced that the US Food and Drug Administration (FDA) will review the ...
-
February 12, 2013
We maintain a Neutral rating on KB Home (KBH) following appraisal of the second quarter 2012 results. KB Home's ...
-
February 11, 2013
Recently, Gilead Sciences, Inc. (GILD) completed its acquisition of Canada-based drug development company, YM ...
-
February 07, 2013
Protalix BioTherapeutics, Inc. (PLX) recently confirmed that it has hired Citigroup, Inc. C) to explore strategic ...
-
February 07, 2013
Idenix Pharmaceuticals, Inc. (IDIX) recently announced that the company has decided to discontinue its clinical ...
-
February 07, 2013
Medivation, Inc. (MDVN) recently announced that its partner Astellas Pharma Inc. (ALPMY) reported Xtandi ...
-
February 07, 2013
Vivus Inc. (VVUS) recently announced the publication of results from a study regarding its weight-loss drug, Qsymia. ...
-
February 05, 2013
Gilead Sciences, Inc.'s (GILD) fourth quarter 2012 earnings (excluding special items but including stock option ...
-
February 04, 2013
Seattle Genetics Inc. (SGEN) recently received approval from Health Canada for its oncology drug, Adcetris ...
-
January 29, 2013
On Jan 28, we maintained a Neutral recommendation on Vulcan Materials Company (VMC) despite poor third quarter ...
-
January 29, 2013
PulteGroup Inc (PHM) is set to report fourth quarter 2012 results on Jan 31. Last quarter it posted an earnings ...
-
January 29, 2013
Discouraging home sales data overshadowed better-than-expected reports on durable orders, dragging the S&P 500 and ...
